🔍 RecallPedia

Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only, Manufactured by: Genzyme Corporation, 500 Kendall Street, Cambridge, MA 02142 A Sanofi Company Country of Origin : United Kingdom, NDC 0024-5862-01

Class I - Dangerous
💊 Drugs Recalled: August 4, 2016 Genzyme Corporation / Genzyme Biosurgery Prescription Drugs Nationwide

What Should You Do?

  1. Check if you have this product:
    Lot # 5RZ002; Exp. 04/18
  2. Do not eat it: Even if it looks and smells fine, do not consume this product.
  3. Throw it away or return it: You can return the product to the store for a full refund.
  4. Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
  5. Report problems: Report any issues to the FDA's Safety Reporting Portal.

⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.

Recall Details

Company:
Genzyme Corporation / Genzyme Biosurgery
Reason for Recall:
Labeling: Incorrect or Missing Lot and/or Exp. Date
Classification:
Class I - Dangerous

Dangerous or defective products that predictably could cause serious health problems or death.

Status:
terminated

Product Information

Full Description:

Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only, Manufactured by: Genzyme Corporation, 500 Kendall Street, Cambridge, MA 02142 A Sanofi Company Country of Origin : United Kingdom, NDC 0024-5862-01

Product Codes/Lot Numbers:

Lot # 5RZ002; Exp. 04/18

Official Source

Always verify recall information with the official FDA source:

View on FDA.gov

FDA Recall Number: D-1518-2016

Related Recalls